• CATALOG PDF Download
  • BROCHURES PDF Download

Human CRF ELISA kit - Reference

Product List

Product Name Cat# Quantity



CRF, ELISA (High Sensitivity)


Anti CRF (24-41)

YII-Y210-EX 50UL

Anti CRF (3-41)

YII-Y211-EX 50UL

1.     Vale W, Spiess J, Rivier C, Rivier J: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 213, 1394-1397, 1981

2.     Shibahara S, Morimoto Y, Furutani Y, Notake M, Takahashi H, Shimizu S, Horikawa S, Numa S: Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J, 2, 775-779, 1983

3.     Rivier J, Spiess J, Vale W: Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci USA, 80, 4851-4855, 1983

4.     Seasholtz AF, Bourbonais FJ, Harnden CE, and Camper SA: Nucleotide Sequence and Expression of the Mouse Corticotropin-Releasing Hormone Gene. Mol Cell Neurosci, 2, 266-273, 1991

5.     Nakane T, Audhya T, Hollander CS, Schlesinger DH, Kardos P, Brown C, Passarelli J: Corticotrophin-releasing factor in extra-hypothalamic brain of the mouse: demonstration by immunoassay and immunoneutralizaion of bioassayable activity. J Endocrinol, 111, 143-149, 1986

6.     Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, Nemeroff CB: Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci, 6, 2908-2914, 1986

7.     Ur E, Grossman A: Corticotropin-releasing hormone in health and disease: an update. Acta Endocrinol (Copenh), 127, 193-199. Review, 1992

8.     Geracioti TD Jr, Orth DN, Ekhator NN, Blumenkopf B, Loosen PT: Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J Clin Endocrinol Metab, 74, 1325-1330, 1992

9.     May C, Rapoport SI, Tomai TP, Chrousos GP, Gold PW: Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease. Neurology, 37, 535-538, 1987

10.Davis KL, Mohs RC, Marin DB, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V: Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry, 56, 981-987, 1999

 11.     Behan DP, Khongsaly O, Owens MJ, Chung HD, Nemeroff CB, De Souza EB: Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain. J Neurochem, 68, 2053-2060, 1997

 12.     Behan DP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, De Souza EB: Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature, 378, 284-287, 1995

 13.     Pedersen WA, McCullers D, Culmsee C, Haughey NJ, Herman JP, Mattson MP: Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol Dis, 8, 492-503, 2001

 14.     Tsuchihashi T, Yamaguchi K, Abe K, Yanaihara N, Saito S: Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors. Jpn J Clin Oncol, 22, 232-237, 1992

To be used for research only. DO NOT use for human gene therapy or clinical diagnosis.